NC
ONC

NewSquare Capital’s BeOne Medicines Ltd ONC Stock Holding History

NewSquare Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35
Closed -$8.47K – 1295
2025
Q2 		$8.47K Buy
35
+21
+150% +$5.15K ﹤0.01% 691
2025
Q1 		$3.81K Buy
+14
New +$3.27K ﹤0.01% 738

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewSquare Capital's ONC Position: Q3 2025 in Review

NewSquare Capital sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 35 shares — an estimated $8.47K sold.

NewSquare Capital first reported a position in ONC in Q1 2025 and held it in 2 quarters. The position peaked at $8.47K in Q2 2025. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • NewSquare Capital reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 35 BeOne Medicines Ltd shares in Q3 2025, an estimated $8.47K.
  • NewSquare Capital first reported a position in BeOne Medicines Ltd in Q1 2025 and held it in 2 quarters.
  • NewSquare Capital's BeOne Medicines Ltd position peaked at $8.47K in Q2 2025.
  • 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.